Kazufumi Katayama

Osaka, 5610825, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Novel Adjuvant S-540956 Targets Lymph Nodes and Reduces Genital Recurrences and Vaginal Shedding of HSV-2 DNA When Administered with HSV-2 Glycoprotein D as a Therapeutic Vaccine in Guinea Pigs.

Novel Adjuvant S-540956 Targets Lymph Nodes and Reduces Genital Recurrences and Vaginal Shedding of HSV-2 DNA When Administered with HSV-2 Glycoprotein D as a Therapeutic Vaccine in Guinea Pigs.

Journal: Viruses

Published: April 01, 2023

S-540956, a CpG Oligonucleotide Annealed to a Complementary Strand With an Amphiphilic Chain Unit, Acts as a Potent Cancer Vaccine Adjuvant by Targeting Draining Lymph Nodes.

S-540956, a CpG Oligonucleotide Annealed to a Complementary Strand With an Amphiphilic Chain Unit, Acts as a Potent Cancer Vaccine Adjuvant by Targeting Draining Lymph Nodes.

Journal: Frontiers in immunology

Published: October 27, 2021

A novel RORγt inhibitor is a potential therapeutic agent for the topical treatment of psoriasis with low risk of thymic aberrations.

A novel RORγt inhibitor is a potential therapeutic agent for the topical treatment of psoriasis with low risk of thymic aberrations.

Journal: Journal of dermatological science

Published: September 03, 2018

Antibodies against adenovirus fiber and penton base proteins inhibit adenovirus vector-mediated transduction in the liver following systemic administration.

Antibodies against adenovirus fiber and penton base proteins inhibit adenovirus vector-mediated transduction in the liver following systemic administration.

Journal: Scientific reports

Published: April 10, 2018

Ablation of IL-17A leads to severe colitis in IL-10-deficient mice: implications of myeloid-derived suppressor cells and NO production.

Ablation of IL-17A leads to severe colitis in IL-10-deficient mice: implications of myeloid-derived suppressor cells and NO production.

Journal: International immunology

Published: February 08, 2018

Allergen-specific sublingual immunotherapy is dose and duration dependent in a murine allergic rhinitis model.

Allergen-specific sublingual immunotherapy is dose and duration dependent in a murine allergic rhinitis model.

Journal: The Journal of allergy and clinical immunology

Published: October 02, 2017

A novel murine model of Japanese cedar pollinosis for characterizing allergen-specific sublingual immunotherapy.

A novel murine model of Japanese cedar pollinosis for characterizing allergen-specific sublingual immunotherapy.

Journal: Nihon yakurigaku zasshi. Folia pharmacologica Japonica

Published: August 11, 2017

Rapid development of antigen-induced airway inflammation in cloned mice generated by nuclear transfer of antige-specific CD4+ T cells.

Rapid development of antigen-induced airway inflammation in cloned mice generated by nuclear transfer of antige-specific CD4+ T cells.

Journal: Nihon yakurigaku zasshi. Folia pharmacologica Japonica

Published: August 11, 2017

Involvement of taste receptors in the effectiveness of sublingual immunotherapy.

Involvement of taste receptors in the effectiveness of sublingual immunotherapy.

Journal: Allergology international : official journal of the Japanese Society of Allergology

Published: June 14, 2017

Identification of biomarker sets for predicting the efficacy of sublingual immunotherapy against pollen-induced allergic rhinitis.

Identification of biomarker sets for predicting the efficacy of sublingual immunotherapy against pollen-induced allergic rhinitis.

Journal: International immunology

Published: January 16, 2017

Hyper-reactive cloned mice generated by direct nuclear transfer of antigen-specific CD4+ T cells.

Hyper-reactive cloned mice generated by direct nuclear transfer of antigen-specific CD4+ T cells.

Journal: EMBO reports

Published: September 09, 2016

Suppression of leaky expression of adenovirus genes by insertion of microRNA-targeted sequences in the replication-incompetent adenovirus vector genome.

Suppression of leaky expression of adenovirus genes by insertion of microRNA-targeted sequences in the replication-incompetent adenovirus vector genome.

Journal: Molecular therapy. Methods & clinical development

Published: January 01, 2014

Showing 1-12 of 25

Last Updated: 09/26/2026